Al Nahdi Medical Company SCJSC
SAU:4164
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| SA |
|
Al Nahdi Medical Company SCJSC
SAU:4164
|
16.8B SAR |
Loading...
|
|
| ZA |
C
|
Clicks Group Ltd
JSE:CLS
|
76.5B ZAR |
Loading...
|
|
| ZA |
D
|
Dis-Chem Pharmacies Ltd
JSE:DCP
|
30.3B ZAR |
Loading...
|
|
| US |
|
Walgreens Boots Alliance Inc
NASDAQ:WBA
|
10.4B USD |
Loading...
|
|
| BR |
|
Raia Drogasil SA
BOVESPA:RADL3
|
45.2B BRL |
Loading...
|
|
| JP |
|
Tsuruha Holdings Inc
TSE:3391
|
1.2T JPY |
Loading...
|
|
| JP |
|
MatsukiyoCocokara & Co
TSE:3088
|
1T JPY |
Loading...
|
|
| CN |
|
Yifeng Pharmacy Chain Co Ltd
SSE:603939
|
30.7B CNY |
Loading...
|
|
| JP |
|
Welcia Holdings Co Ltd
TSE:3141
|
657.7B JPY |
Loading...
|
|
| JP |
S
|
Sugi Holdings Co Ltd
TSE:7649
|
640.3B JPY |
Loading...
|
|
| JP |
|
Cosmos Pharmaceutical Corp
TSE:3349
|
570.5B JPY |
Loading...
|
Market Distribution
| Min | -6 635.9% |
| 30th Percentile | 1.8% |
| Median | 8.5% |
| 70th Percentile | 15.1% |
| Max | 3 211.1% |
Other Profitability Ratios
Al Nahdi Medical Company SCJSC
Glance View
Al Nahdi Medical Company SCJSC has entrenched itself as a prominent player within Saudi Arabia’s expansive healthcare and retail landscape. Founded in 1986, the company embarked on its journey as a single pharmacy in Jeddah, gradually evolving into the leading pharmacy retail chain in the Kingdom. This evolution is interwoven with the region’s healthcare development, echoing the burgeoning demands of a population increasingly focused on wellness and access to quality health products. Al Nahdi’s strategy hinges on an expansive network of over 1,100 outlets, strategically located not only to ensure accessibility but also to foster strong community ties by providing crucial health services and over-the-counter medications. The company's mission stretches beyond mere business growth; it strives to act as a supportive pillar in the community, exemplified by initiatives such as education programs and promoting public health awareness. Al Nahdi’s business model thrives on diversification and integration within the healthcare supply chain. Core revenue streams derive from retail sales of pharmaceuticals, cosmetics, and personal care products, enhanced by a digital presence that captures the rising trend of online shopping. Their omnichannel strategy, combining physical stores with a robust e-commerce platform, presents a seamless shopping experience tailored to the modern consumer. The company also capitalizes on strategic partnerships and alliances to enhance its product offerings, ensuring that it stays ahead in the competitive landscape. Through its efficient logistics network, Al Nahdi guarantees timely delivery and product availability, which are essential to maintaining customer loyalty and market leadership. This blend of expansive reach, customer-centric service, and strategic foresight not only fuels its profitability but solidifies its position as a healthcare cornerstone across the region.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Al Nahdi Medical Company SCJSC is 8.1%, which is below its 3-year median of 9.4%.
Over the last 3 years, Al Nahdi Medical Company SCJSC’s Net Margin has decreased from 10.7% to 8.1%. During this period, it reached a low of 8.1% on Sep 30, 2025 and a high of 10.7% on Sep 30, 2022.